Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > Here's Why This Is Such a Great Buy Right NOW!!!

<< Previous

Bullboard Posts

Next >>

Comment by Vette81on Jun 19, 2018 8:16pm

72 Views

Post# 28195570

RE:Here's Why This Is Such a Great Buy Right NOW!!!

If each of your 12 points results in a double up this is creative math. 8 cents to 16, 16 to 32, 32 to 64, 64 to 1.28, 1.28 to 2.56, 2.56 to 5.12, 5.12 to 10.24, 10.24 to 20.28, 20.28 to 40.56, 40.56 to 81.12, 81.12 to 162.24, 162.24 to 324.48. And this is where some heavy duty pharma companies are on the stock exchange.

<< Previous

Bullboard Posts

Next >>

The top 5 Canadian small-cap AI stocks